SkinHealth Systems Inc.
- SKIN · Nasdaq
- Surgical & Medical Instruments & Apparatus
- Long Beach, CA
- 613 employees
- CIK 0001818093
Updated from SEC filings through
Top things to know
Executives
-
Pedro Bruno Ferreira Malha President and CEO 4, 2026-03-24 -
Michael Monahan Chief Financial and Operating Officer 8-K, 2026-09-10 -
Michael P. Monahan Chief Financial Officer 4, 2026-08-12
What leadership is saying
“Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction”
Earnings press release (8-K Ex. 99.1), filed November 5, 2026
SkinHealth Systems Inc. is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Long Beach, CA. It trades as SKIN on Nasdaq. Revenue was $301M in the fiscal year ending December 31, 2025, -10.0% from the year before. It reported about 613 employees. Pedro Bruno Ferreira Malha is President and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $301M 10-K, 2026-03-12 | $334M 10-K, 2026-03-12 | $398M 10-K, 2026-03-12 | $366M 10-K, 2025-03-12 | $260M 10-K, 2024-03-12 |
| Operating income | -$20.8M 10-K, 2026-03-12 | -$67.8M 10-K, 2026-03-12 | -$131M 10-K, 2026-03-12 | -$25.8M 10-K, 2025-03-12 | -$39.9M 10-K, 2024-03-12 |
| SG&A | $212M 10-K, 2026-03-12 | $244M 10-K, 2026-03-12 | $276M 10-K, 2026-03-12 | $266M 10-K, 2025-03-12 | $210M 10-K, 2024-03-12 |
| Net income | -$9.5M 10-K, 2026-03-12 | -$29.1M 10-K, 2026-03-12 | -$100M 10-K, 2026-03-12 | $44.2M 10-K, 2025-03-12 | -$379M 10-K, 2024-03-12 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| | President and CEO | 4, 2026-03-24 |
| | Chief Financial and Operating Officer | 8-K, 2026-09-10 |
| | Chief Financial Officer | 4, 2026-08-12 |
| Kenneth Tripp | Board member (per proxy) bio: AUDIT COMMITTEE | DEF 14A, 2026-04-24 |
| Brenton L. Saunders | Board member (per proxy) bio: Chairman of the Board | DEF 14A, 2026-08-12 |
| Brian Miller | Director | 10-K, 2026-03-12 |
| Desiree Gruber | Director | 10-K, 2026-03-12 |
| Doug Schillinger | Director | 10-K, 2026-03-12 |
| Michelle Kerrick | Director | 10-K, 2026-03-12 |
| Philippe Schaison | Director | 10-K, 2026-03-12 |
| Stephen J. Fanning | Director | 10-K, 2026-03-12 |
What SkinHealth Systems Inc. does
The Beauty Health Company (the “Company” or “we”) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 6.5 million (as of November 2, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Public float | $158M (as of June 30, 2025) | 10-K, March 12, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting September 22, 2026 (filed August 12, 2026) | DEF 14A, August 12, 2026 |
| Auditor | Deloitte & Touche LLP (Los Angeles, California) | Latest 10-K |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-14
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-06
- Item 1.02 Termination of a material definitive agreement
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-09-28
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-09-10
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-08-14
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-08-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-22
- Item 8.01 Other events
- 8-K filed 2026-06-16
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-12
- Item 3.01 Notice of delisting or failure to meet listing standards
Frequently asked questions about SkinHealth Systems Inc.
- What does SkinHealth Systems Inc. do?
- In its own words, from Item 1 of its 10-K: "The Beauty Health Company (the “Company” or “we”) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers."
- What is SkinHealth Systems Inc.'s revenue?
- $301M for the fiscal year ending December 31, 2025, from its 10-K filed March 12, 2026.
- Is SkinHealth Systems Inc. profitable?
- SkinHealth Systems Inc. reported net income of -$9.5M for the fiscal year ending December 31, 2025.
- How many employees does SkinHealth Systems Inc. have?
- About 613 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of SkinHealth Systems Inc.?
- Pedro Bruno Ferreira Malha, President and CEO, as named in a 4 filed March 24, 2026.
- Who is the CFO of SkinHealth Systems Inc.?
- Michael Monahan, Chief Financial and Operating Officer, as named in a 8-K filed September 10, 2026.
- Where is SkinHealth Systems Inc. headquartered?
- Long Beach, CA.
- What is SkinHealth Systems Inc.'s stock ticker?
- SKIN on Nasdaq.
- What industry is SkinHealth Systems Inc. in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is SkinHealth Systems Inc.'s website?
- beautyhealth.com.
- When does SkinHealth Systems Inc. report earnings next?
- February 4, 2027. Source: estimate_8k_pattern.
- Is SkinHealth Systems Inc. a public company?
- Yes. SkinHealth Systems Inc. files with the SEC under CIK 0001818093 and trades as SKIN.
- Who audits SkinHealth Systems Inc.?
- Deloitte & Touche LLP, Los Angeles, California, as named in its latest annual report (10-K).
- How many shares of SkinHealth Systems Inc. are outstanding?
- 6.5 million shares as of November 2, 2026, from its 10-Q filed November 5, 2026.
- What is SkinHealth Systems Inc.'s public float?
- $158M as of June 30, 2025, as reported on the cover of its 10-K filed March 12, 2026.
- How many business segments does SkinHealth Systems Inc. report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is SkinHealth Systems Inc.'s annual shareholder meeting?
- September 22, 2026, per its proxy statement (DEF 14A) filed August 12, 2026.